References
- Asgar AW, Mack MJ, Stone G. Secondary mitral regurgitation in heart failure. Pathophysiology, prognosis, and therapeutic considerations. JACC. 2015;65:1231–1248. doi:10.1016/j.jacc.2015.02.009.
- Franzen O, van der Heyden J, Baldus S, et al. MitraClip therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13:569–576. doi:10.1093/eurjhf/hfr029.
- Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31:1373–1381. doi:10.1093/eurheartj/ehj050.
- Feldman T, Kar S, Rinaldi M, et al. EVEREST investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular valve edge-to-edge repair study) cohort. J Am Coll Cardiol. 2009;54:686–694. doi:10.1016/j.jacc.2009.03.077.
- Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802. doi:10.1016/S0894-7317(03)00335-3.
- Vahanian A, Alfieri O, Andreotti F, et al. Joint task force on the management of valvular heart disease of the European society of cardiology (ESC); European association for cardio-thoracic surgery (EACTS). ESC/EACTS guidelines on the management of valvular heart disease (version 2012). The joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2012;33:2451–2496.
- Lancellotti P, Moura L, Pierard LA, et al. European association of echocardiography. European association echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307–332. doi:10.1093/ejechocard/jeq031.
- Chiampan A, Nahum J, Leye M, et al. Determinants of regurgitant volume in mitral regurgitation: contrasting effect of similar effective regurgitant orifice area in functional and organic mitral regurgitation. Eur J Echocardiogr. 2012;13:324–329.
- Herrmann HC, Kar S, Siegel R, et al. EVEREST investigators. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention. 2009;4:437–442. doi:10.4244/EIJV4I4A76.
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307–2318. doi:10.1056/NEJMoa1806640.
- Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297–2306. doi:10.1056/NEJMoa1805374.
- Pleger ST, Chorianopoulos E, Krumsdorf U, Katus HA, Bekeredjian R. Percutaneous edge-to-edge repair of mitral regurgitation as a bail-out strategy in critically ill patients. J Invasive Cardiol. 2013;25:69–72.
- Bilge M, Alemdar R, Yasar AS. Successful percutaneous mitral valve repair with the MitraClip system of acute mitral regurgitation due to papillary muscle rupture as complication of acute myocardial infarction. Catheter Cardiovasc Interv. 2014;83:e137–40. doi:10.1002/ccd.24960.
- Adamo M, Barbanti M, Curello S, et al. Effectiveness of MitraClip therapy in patients with refractory heart failure. J Interv Cardiol. 2015;28:61–68. doi:10.1111/joic.12179.